Product information

Current status:

Cancelled Pre Market

Current status date:

2017-08-25

Original market date: ^{See footnote 1}

Product name:

GABAPENTIN

DIN:

02238671 Electronic product monograph is not available

Company:

OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.
2200 Eglinton Avenue, East
Scarborough
Ontario
Canada M1L 2N3

Class:

Human

Dosage form(s):

Capsule

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

PRESCRIPTION

American Hospital Formulary Service (AHFS): ^{See footnote 3}

28:12.92 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N02BF01 GABAPENTIN

Active ingredient group (AIG) number:^{See footnote5}

0125929001